| Financial Year |
March 31 2023 |
| Monetary Funds |
266,893,847.63 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
51,766,449.86 |
| Advances to Suppliers |
6,290,076.93 |
| Other Receivables |
7,760,322.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
194,378,736.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,398,480.31 |
| Total Current Assets |
529,487,913.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,363,985,772.13 |
| Under-construction Projects |
661,500.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
594,165,100.00 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
93,480,148.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,766,990.26 |
| Deferred Income Tax Assets |
2,158,857.27 |
| Other Non-Current Assets |
1,127,606.46 |
| Sub-Total of Non-Current Assets |
2,101,190,946.76 |
| Total Assets |
2,630,678,859.81 |
| Short-Term Loans |
525,731,752.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
37,600,000.00 |
| Accounts Payable |
126,555,414.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,770,705.37 |
| Taxes Payable |
6,824,787.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,805,459.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,353,435.72 |
| Other Current Liabilities |
790,695.11 |
| Sub-Total of Current Liabilities |
759,185,722.05 |
| Long-term Loans |
428,158,112.95 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
518,383.84 |
| Deferred Income Tax Liabilities |
4,884,856.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
504,698,032.47 |
| Total Liabilities |
1,263,883,754.52 |
| Paid-In Capital(Or Share Stock) |
196,698,691.00 |
| Capital Surplus |
545,751,074.11 |
| Surplus Reserve |
46,541,301.52 |
| LESS:Treasury Stock |
8,069,034.24 |
| Undistributed Profits |
585,873,072.90 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,366,795,105.29 |
| Owner's Equity（Stockholder's Equity） |
1,366,795,105.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,630,678,859.81 |
